DUBLIN, Jan. 10, 2024 /PRNewswire/ — The “Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
In a pivotal development for the preventive healthcare technologies and services market, a newly published research publication has been added to our comprehensive suite of industry reports. This in-depth analysis, focusing on current trends, market size, and forecasted growth, sheds light on an increasingly crucial segment within the global healthcare paradigm.
According to the market study, the global preventive healthcare technologies and services market is set for a considerable upsurge, with projections indicating a value of USD 585.6 billion by 2030. The anticipated growth is at a Compound Annual Growth Rate (CAGR) of 11.8% from 2023 to 2030—an expansion driven by rising awareness and the proactive adoption of preventive measures.
The significance of early detection and screening technologies cannot be overstated, as they form a substantial part of the preventive approach, heralding personalized healthcare solutions. This segment’s dominance is underpinned by the ever-increasing precision and sophistication of diagnostic methods, paving the way for timely intervention in disease management.
In a market subset analysis, vaccines have played a commendable role in propelling the sector forward, with an uptick in immunization efforts worldwide contributing to overall market expansion. Furthermore, burgeoning healthcare technologies focused on chronic disease management illustrates the sector’s dynamic nature and its response to global health trends.
North America continues to lead with a commanding revenue share, buoyed by technological advancements and comprehensive healthcare policies. However, the spotlight also shines on the Asia Pacific region, where emergent economies are forecasted to exhibit robust growth exceeding CAGR expectations of 14.2%. This acceleration is spearheaded by vigorous governmental initiatives tailored to enhance population health outcomes.
The research piece underscores the intersection of technology and healthcare, pointing towards a synergistic evolution of the two domains. High-definition screening methods and smart diagnostic devices are among the breakthroughs fuelling this ascent.
With the relentless pursuit for longevity and quality of life at its core, preventive healthcare is emerging as a focal investment area, loaded with potential for yielding both human and economic dividends.
This comprehensive report serves as an essential resource for stakeholders and market participants seeking to navigate the expansive realm of preventive healthcare technologies and services, peering into the looming decade of transformation.
For those with a vested interest in healthcare innovation, chronic disease management frameworks, and the bolstering of vaccine strategies, the findings encapsulated within this analysis present a significant encyclopedic asset.
Understanding the market dynamics and recognizing the opportunities laid out in this preventive healthcare technologies and services market report are crucial for strategic decision-making and long-term planning within the healthcare industry.
Companies Mentioned
- Myriad Genetics, Inc.
- Quest Diagnostics Incorporated
- Medtronic
- Abbott
- Merck & Co., Inc.
- GSK plc
- Omnicell
- MCKESSON CORPORATION
For more information about this report visit https://www.researchandmarkets.com/r/s84iyj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
